Mr. Ron Nagar reports

TEMPRAMED LAUNCHES NEW PRODUCT "VIVI MED," UNLOCKING NEW GROWTH OPPORTUNITIES IN HIGH-VALUE BIOLOGICS AND INJECTABLE MEDICATIONS

Tempramed Technologies Ltd. has launched commercially VIVI Med, a new temperature-protection solution designed to safeguard medication vials, biologics and other critical therapies that fall outside the insulin-pen format.

The launch of VIVI Med provides significant expansion of the company's total addressable market opportunity, by extending its proven thermal-protection technology into new drug categories, broader patient populations and higher-value use cases. By addressing medications such as GLP-1 receptor agonists, biologics including Humira, insulin vials, injectable medication vials and temperature-sensitive blood glucose test strips, VIVI Med substantially increases the scope of the company's commercial reach.

As the global use of biologics, GLP-1 therapies and specialty injectables continues to grow across chronic, autoimmune and metabolic conditions, the need for reliable, portable and power-free temperature protection is becoming increasingly critical. VIVI Med is engineered to provide 24/7/365 passive protection for years -- without batteries, charging or maintenance-supporting real-world use across travel, work and active lifestyles.

"To date, our product portfolio has focused on insulin pens and epinephrine auto-injectors, but the medication landscape is evolving rapidly," said Ron Nagar, chief executive officer of Tempramed. "VIVI Med is a strategic expansion of our platform that allows us to address a much broader universe of temperature-sensitive medications, many of which are high-value biologics with growing patient populations. This product materially expands our addressable market and creates new opportunities across consumer, B2B and health-care-system channels. Using our proprietary, patented technology, we will continue to expand our product portfolio with new products, new applications and new markets."

Key features of VIVI Med

• Expanded compatibility: designed for medications beyond standard insulin pens, including vials, biologics, GLP-1 therapies, alternative epinephrine auto-injectors and temperature- and light-sensitive glucose test strips;

• Year-round temperature protection: Maintains safe medication temperatures without refrigeration, electricity or maintenance;

• Portable and lifestyle-friendly: compact, lightweight, reusable design for daily use, travel and outdoor environments

• Durable, long-life construction: built with space-grade materials and engineered for years of repeated use.

Strategic and commercial significance

With the introduction of VIVI Med, Tempramed now offers a multiformat temperature-protection platform spanning:

• VIVI Cap and VIVI Cap Smart for insulin pens and certain GLP-1 pens;

• VIVI Epi for epinephrine auto-injectors;

• VIVI Med for vials, biologics, GLP-1 pens, test strips and broader injectable formats.

About Tempramed Technologies Ltd.

Tempramed Technologies is a global leader in innovative, temperature-controlled medication storage solutions.

We seek Safe Harbor.